Literature DB >> 2000226

Incidence of mutations at codon 61 of the Ha-ras gene in liver tumors of mice genetically susceptible and resistant to hepatocarcinogenesis.

T A Dragani1, G Manenti, B M Colombo, F S Falvella, M Gariboldi, M A Pierotti, G Della Porta.   

Abstract

By selective oligonucleotide hybridization of polymerase chain reaction (PCR) amplified tumor DNAs we have analysed the incidence of mutations at codon 61 of the Ha-ras gene in 42 liver tumors spontaneously developed in Balb/c, C3Hf and B6C3 male mice, and in 79 liver tumors induced by the chemical carcinogens diethylnitrosamine (NDEA) and urethan in B6C3 and B6C male and female mice. The incidence of Ha-ras gene mutations in both spontaneously developed and urethan-induced liver tumors was 50%-63% in mice genetically susceptible to hepatocarcinogenesis (C3Hf, B6C3) and 7%-9% in mice genetically resistant (Balb/c, B6C). Urethan-induced tumors showed about the same incidence of ras mutations in male and in female B6C3 mice. NDEA-induced tumors showed a low incidence of Ha-ras mutations in both the hybrid mice (3/18 and 1/13 in B6C3 and B6C male mice, respectively). The most frequently found mutations were a C----A transversion at the 1st base of codon 61 in spontaneous tumors, and an A----T transversion at the 2nd base in urethan-induced tumors. Our results indicate that liver tumors induced by NDEA or urethan or spontaneously arisen have a different pattern of Ha-ras mutations at codon 61 and that these mutations constitute a rare molecular alteration in the pathogenesis of liver tumors in genetically resistant mice.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2000226

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  6 in total

1.  ARF suppresses hepatic vascular neoplasia in a carcinogen-exposed murine model.

Authors:  Stephanie E Busch; Kay E Gurley; Russell D Moser; Christopher J Kemp
Journal:  J Pathol       Date:  2012-05-08       Impact factor: 7.996

2.  Conditional transformation of mouse liver epithelial cells. An in vitro model for analysis of genetic events in hepatocarcinogenesis.

Authors:  G H Lee; K Ogawa; N R Drinkwater
Journal:  Am J Pathol       Date:  1995-12       Impact factor: 4.307

3.  Tumorigenicity of acrylamide and its metabolite glycidamide in the neonatal mouse bioassay.

Authors:  Linda S Von Tungeln; Daniel R Doerge; Gonçalo Gamboa da Costa; M Matilde Marques; William M Witt; Igor Koturbash; Igor P Pogribny; Frederick A Beland
Journal:  Int J Cancer       Date:  2012-03-28       Impact factor: 7.396

4.  Biological Basis of Differential Susceptibility to Hepatocarcinogenesis among Mouse Strains.

Authors:  Robert R Maronpot
Journal:  J Toxicol Pathol       Date:  2009-04-06       Impact factor: 1.628

5.  Overproduction of thrombopoietin by BRAFV600E-mutated mouse hepatocytes and contribution of thrombopoietin to hepatocarcinogenesis.

Authors:  Hiroki Tanaka; Kie Horioka; Masahiro Yamamoto; Masaru Asari; Katsuhiro Okuda; Kosuke Yamazaki; Keiko Shimizu; Katsuhiro Ogawa
Journal:  Cancer Sci       Date:  2019-07-30       Impact factor: 6.716

6.  Role of the BrafV637E mutation in hepatocarcinogenesis induced by treatment with diethylnitrosamine in neonatal B6C3F1 mice.

Authors:  Masahiro Yamamoto; Hiroki Tanaka; Bing Xin; Yuji Nishikawa; Kosuke Yamazaki; Keiko Shimizu; Katsuhiro Ogawa
Journal:  Mol Carcinog       Date:  2016-06-10       Impact factor: 4.784

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.